首页|基于真实世界监测数据分析山东省PD-1抑制剂不良反应发生特点

基于真实世界监测数据分析山东省PD-1抑制剂不良反应发生特点

扫码查看
目的:挖掘PD-1抑制剂不良反应发生规律及特点,为使用PD-1抑制剂的患者用药安全提供依据。方法:调取2019年4月至2023年5月山东省药品不良反应监测管理系统收集的PD-1抑制剂相关不良反应,对不良反应的类型、严重程度、是否非预期及患者性别、年龄、转归情况、累及器官/系统等进行统计学处理。结果:1 056例PD-1抑制剂相关不良反应报道中,以男性患者为主(74。91%),年龄主要分布在大于65岁(49。53%),涉及18个系统器官分类,1 672个首选术语,其中窒息感为所有药品均未报道过的首选术语。发生严重不良反应的患者为609例,占比57。67%,对导致严重不良反应不同因素比较发现,发生严重不良反应组超说明书/指南用药情况及既往药品不良反应/事件发生情况与一般不良反应组相比差异有统计学意义(P<0。05)。结论:临床医师在使用PD-1抑制剂时应关注其不良反应发生规律及特点,加强不良反应监测,保障用药安全。
Analysis of adverse reaction characteristics of PD-1 inhibitors in Shandong Province based upon real-world monitoring data
OBJECTIVE To excavate the patterns and characteristics of adverse reactions of PD-1 inhibitors and provide rationales for patient medication safety.METHODS The adverse reactions of PD-1 inhibitor collected by Shandong ADR Moni-toring Center from April 2019 to May 2023 were retrieved.Statistical analysis was performed on types of adverse reactions,sever ity,unintended or not,patient gender,age,outcome and involved organs/systems.RESULTS Among 1 056 reports of adverse reactions related to PD-1 inhibitors,males dominated(74.91%)with age mostly over 65 year(49.53%).A total of 18 system organ classifications(SOCs)and 1 672 preferred terms(PTs)were involved,with choking sensation as a PT not reported for any of the drugs.And 609 patients with severe ADR occurred,accounting for 57.67%.A comparison of different factors leading to severe adverse drug reaction revealed a significant statistical difference between group with serious adverse drug reactions and group with general adverse drug reaction during off-label drug uses and the previous of adverse drug reaction/event.CONCLUSION Clinicians should pay a high alert for the occurring patterns and characteristics of adverse reactions of PD-1 inhibitors and strengthen the monitoring of adverse drug reactions to ensure the safety of drug dosing.

PD-1 inhibitoradverse reactionsserious adverse drug reactionsdrug safety

路支超、孟艳丽、张霞、邹静雯、张歆、许莉莉

展开 >

淄博市市立医院临床药学办公室,山东淄博 255400

山东省淄博市药物警戒中心,山东淄博 255086

山东省药品不良反应监测中心药品监测科,山东济南 250014

PD-1抑制剂 不良反应 严重不良反应 用药安全

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(23)